NCT04083976 2026-02-04RAGNARJanssen Research & Development, LLCPhase 2 Active not recruiting316 enrolled 15 charts
NCT04488003 2024-06-04Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF AlterationsBioMed Valley Discoveries, IncPhase 2 Terminated104 enrolled 13 charts